Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease

被引:128
|
作者
Menezes, Luis F. [1 ]
Lin, Cheng-Chao [1 ]
Zhou, Fang [1 ]
Germino, Gregory G. [1 ]
机构
[1] NIDDK, NIH, Bethesda, MD 20892 USA
来源
EBIOMEDICINE | 2016年 / 5卷
关键词
Polycystic kidney disease; Autosomal Dominant Polycystic Kidney Disease; Pkd1; ADPKD; Mouse model; Systems biology; Metabolism; Fatty acid oxidation; Fatty acid oxidation defect; Lipid metabolism; Diet; PLANAR CELL POLARITY; SEX-DIFFERENCES; ILLUMINA MICROARRAY; ENERGY HOMEOSTASIS; INSULIN-RESISTANCE; NETWORK ANALYSIS; CYST FORMATION; IN-VIVO; PKD1; EXPRESSION;
D O I
10.1016/j.ebiom.2016.01.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The major gene mutated in autosomal dominant polycystic kidney disease was first identified over 20 years ago, yet its function remains poorly understood. We have used a systems-based approach to examine the effects of acquired loss of Pkd1 in adult mouse kidney as it transitions from normal to cystic state. Methods: We performed transcriptional profiling of a large set of male and female kidneys, along with metabolomics and lipidomics analyses of a subset of male kidneys. We also assessed the effects of a modest diet change on cyst progression in young cystic mice. Fatty acid oxidation and glycolytic rates were measured in five control and mutant pairs of epithelial cells. Results: We find that females have a significantly less severe kidney phenotype and correlate this protection with differences in lipid metabolism. We show that sex is a major determinant of the transcriptional profile of mouse kidneys and that some of this difference is due to genes involved in lipid metabolism. Pkd1 mutant mice have transcriptional profiles consistent with changes in lipid metabolism and distinct metabolite and complex lipid profiles in kidneys. We also show that cells lacking Pkd1 have an intrinsic fatty acid oxidation defect and that manipulation of lipid content of mouse chow modifies cystic disease. Interpretation: Our results suggest PKD could be a disease of altered cellular metabolism. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:183 / 192
页数:10
相关论文
共 50 条
  • [31] An update on treatments for autosomal dominant polycystic kidney disease
    Patel, Suhani Janak
    Sadowski, Catherine K.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (06): : 11 - 16
  • [32] Cardiovascular complications in autosomal dominant polycystic kidney disease
    Kraatz, G
    Devantier, A
    Ahrendt, S
    Guth, HJ
    Kraatz, U
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 2000, 29 (10) : 498 - 501
  • [33] Modulating in fl ammation with interleukin 37 treatment ameliorates murine Autosomal Dominant Polycystic Kidney Disease
    Zylberberg, Allara K.
    Cottle, Denny L.
    Runting, Jessica
    Rodrigues, Grace
    Tham, Ming Shen
    Jones, Lynelle K.
    Cumming, Helen E.
    Short, Kieran M.
    Zaph, Colby
    Smyth, Ian M.
    KIDNEY INTERNATIONAL, 2023, 105 (04) : 731 - 743
  • [34] A new diet for autosomal dominant polycystic kidney disease
    Taylor, Jacob
    Hamilton-Reeves, Jill
    Sullivan, Debra
    Ptomey, Lauren
    Gibson, Cheryl
    Wesson, Donald
    Gratham, Jared
    FASEB JOURNAL, 2014, 28 (01)
  • [35] Mineral bone disease in autosomal dominant polycystic kidney disease
    Gitomer, Berenice
    Pereira, Renata
    Salusky, Isidro B.
    Stoneback, Jason W.
    Isakova, Tamara
    Cai, Xuan
    Dalrymple, Lorien S.
    Ofsthun, Norma
    You, Zhiying
    Malluche, Harmut H.
    Maddux, Franklin
    George, Diana
    Torres, Vicente
    Chapman, Arlene
    Steinman, Theodore I.
    Wolf, Myles
    Chonchol, Michel
    KIDNEY INTERNATIONAL, 2021, 99 (04) : 977 - 985
  • [36] Assessment of Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease
    Gigante, Antonietta
    Perrotta, Adolfo Marco
    Tinti, Francesca
    Assanto, Eleonora
    Muscaritoli, Maurizio
    Lai, Silvia
    Cianci, Rosario
    APPLIED SCIENCES-BASEL, 2023, 13 (12):
  • [37] Is autosomal dominant polycystic kidney disease an early sweet disease?
    Dachy, Angelique
    Decuypere, Jean-Paul
    Vennekens, Rudi
    Jouret, Francois
    Mekahli, Djalila
    PEDIATRIC NEPHROLOGY, 2022, 37 (09) : 1945 - 1955
  • [38] Drug repurposing in autosomal dominant polycystic kidney disease
    Zhou, Julie Xia
    Torres, Vicente E.
    KIDNEY INTERNATIONAL, 2023, 103 (05) : 859 - 871
  • [39] Cardiac Involvement in Autosomal Dominant Polycystic Kidney Disease
    Spinelli, Letizia
    Giugliano, Giuseppe
    Esposito, Giovanni
    CARDIOGENETICS, 2021, 11 (02) : 39 - 49
  • [40] Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Pharmacokinetics and Implications for Practice
    Hines, Cheryl B.
    Hooper, Gwendolyn L.
    Collins-Yoder, Angela
    NEPHROLOGY NURSING JOURNAL, 2020, 47 (02) : 145 - 150